|
C1ORF144 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.482000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.961800E-01 |
| Normal-vs-Stage2 |
9.994000E-01 |
| Normal-vs-Stage3 |
1.140420E-01 |
| Normal-vs-Stage4 |
1.872230E-01 |
| Stage1-vs-Stage2 |
6.875400E-01 |
| Stage1-vs-Stage3 |
1.539190E-01 |
| Stage1-vs-Stage4 |
3.246200E-01 |
| Stage2-vs-Stage3 |
2.126200E-01 |
| Stage2-vs-Stage4 |
2.903800E-01 |
| Stage3-vs-Stage4 |
9.086400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.441800E-01 |
| Normal-vs-AfricanAmerican |
3.906400E-01 |
| Normal-vs-Asian |
8.140400E-01 |
| Caucasian-vs-AfricanAmerican |
1.494170E-01 |
| Caucasian-vs-Asian |
3.129800E-01 |
| AfricanAmerican-vs-Asian |
5.606200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.492250E-01 |
| Normal-vs-Female |
5.282600E-01 |
| Male-vs-Female |
2.424000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.665800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.821200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.104380E-01 |
| Normal-vs-Age(81-100Yrs) |
2.987400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.908400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.090300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.369800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.538400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.803800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.722000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.443860E-03 |
| Classical-VS-Follicular |
3.858200E-03 |
| Classical-VS-Other |
1.618200E-01 |
| Classical-VS-Normal |
7.482000E-01 |
| Tall-VS-Follicular |
3.627200E-01 |
| Tall-VS-Other |
8.122000E-01 |
| Tall-VS-Normal |
4.363900E-03 |
| Follicular-VS-Other |
8.318800E-01 |
| Follicular-VS-Normal |
3.497600E-02 |
| Other-VS-Normal |
1.644240E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.853600E-01 |
| Normal-vs-N1 |
3.911500E-02 |
| N0-vs-N1 |
1.564950E-01 |
|
|
